Atherosys will provide portable, accurate ultrasound testing for detection of cardiovascular disease using AI software at a 90% cost savings over current ultrasound testing. It does not require a skilled sonographer and can be performed in minutes by primary care office staff, eventually replacing cholesterol testing, which is 100 million tests/year in the US alone.